Medi-Caps Ltd

Medi Caps Ltd share price softened by 0.85% to Rs 26.75 after the company's net profit witnessed a sharp fall of 173.36% to Rs 2.23 crore, while revenue from operations nosedived 20.47% to Rs 2.72 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 24.84 lakh crore, easing 5.02%. It has improved by 1.04% over last one week and heading higher by 11.64% in last one month while the market capitalization of Medi Caps Ltd has inched up 3.30% and 13.56% in the same period respectively. Profit before tax (PBT) of Medi Caps Ltd stood at Rs 2.23 crore in Q2 FY26, tanking 36.10% year-on-year, and tumbling by 173.60% quarter-on-quarter. EBITDA came in at Rs 2 crore, crashing by 49.19% YoY and plunging by 75.42% sequentially. Total expenses reduced by 15.64% to Rs 5.07 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 1.4 crore, going up by 18.64% YoY, while employee benefits expense was at Rs 1.91 crore, declining 11.98% YoY. For the TTM ended FY26, revenue from operations eased 4.48% to Rs 25.37 crore, while net profit tumbled by 74.55% to Rs 0.57 crore, compared to previous TTM. EBITDA tanked by 148% to Rs 4.56 crore, and PBT collapsed by 32.80% to Rs 0.84 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 5.07 crore in FY26, as against Rs 6.94 crore in FY25. Medi Caps Ltd crashed 39.29% in last one year, underperforming the benchmark BSE Sensex which has softened by 2.64% during the same period.

Medi-Caps Limited announced the re-appointment of Alok K. Garg as Chairman Cum Managing Director for three years, effective September 1, 2026, subject to shareholder approval at the 43rd Annual General Meeting. The company also appointed Akshit Garg as Chief Financial Officer and Key Managerial Personnel, effective August 7, 2026, and Mrs. Saloni Garg as an Additional Director and Whole Time Woman Director for three years, also subject to shareholder approval.

Medi-Caps Limited announced the re-appointment of Alok K. Garg as Chairman Cum Managing Director for three years, effective September 1, 2026, pending shareholder approval at the 43rd Annual General Meeting. The company also appointed Akshit Garg as Chief Financial Officer and Key Managerial Personnel, effective August 7, 2026, and Mrs. Saloni Garg as an Additional Director and Whole Time Woman Director for three years, also subject to shareholder approval.

Medi-Caps Limited announced the re-appointment of Alok K. Garg as Chairman Cum Managing Director for three years, effective September 1, 2026, subject to shareholder approval at the 43rd Annual General Meeting. The company also appointed Akshit Garg as Chief Financial Officer and Key Managerial Personnel, effective August 7, 2026, and Mrs. Saloni Garg as an Additional Director and Whole Time Woman Director for three years, also subject to shareholder approval.

Medi-Caps Limited will hold a meeting of its Board of Directors on August 6, 2026, to consider and approve the standalone and consolidated unaudited financial results for the quarter ended June 30, 2026, according to a filing with the BSE Limited. The company’s BSE scrip code is 523144 and its ISIN is INE442D01010. Trading window for dealing in the company’s securities will open 48 hours after the declaration of the financial results for designated persons, immediate relatives, and connected persons.

Net profit of Medi Caps rose 76.74% to Rs 3.04 crore in the quarter ended March 2026 as against Rs 1.72 crore during the previous quarter ended March 2025. Sales declined 50.72% to Rs 3.42 crore in the quarter ended March 2026 as against Rs 6.94 crore during the previous quarter ended March 2025. For the full year,net loss reported to Rs 3.04 crore in the year ended March 2026 as against net loss of Rs 0.57 crore during the previous year ended March 2025. Sales declined 51.12% to Rs 12.40 crore in the year ended March 2026 as against Rs 25.37 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales3.426.94 -51 12.4025.37 -51 OPM %-60.23-3.31 --75.89-7.21 - PBDT3.531.89 87 -1.220.88 PL PBT3.031.45 109 -3.02-0.84 -260 NP3.041.72 77 -3.04-0.57 -433 Powered by Capital Market - Live

Medi Caps will hold a meeting of the Board of Directors of the Company on 21 May 2026.

Net Loss of Medi Caps reported to Rs 0.77 crore in the quarter ended December 2025 as against net loss of Rs 2.05 crore during the previous quarter ended December 2024. Sales rose 6.98% to Rs 4.29 crore in the quarter ended December 2025 as against Rs 4.01 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales4.294.01 7 OPM %-24.71-44.39 - PBDT-0.30-1.62 81 PBT-0.74-2.05 64 NP-0.77-2.05 62 Powered by Capital Market - Live

Medi Caps will hold a meeting of the Board of Directors of the Company on 11 February 2026.Powered by Capital Market - Live

Net loss of Medi Caps reported to Rs 1.82 crore in the quarter ended September 2025 as against net profit of Rs 0.31 crore during the previous quarter ended September 2024. Sales declined 75.72% to Rs 2.01 crore in the quarter ended September 2025 as against Rs 8.28 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales2.018.28 -76 OPM %-144.785.43 - PBDT-1.380.74 PL PBT-1.820.31 PL NP-1.820.31 PL Powered by Capital Market - Live